Medical News

RSS

Scientists discover that bacteria have the capability to clean wastewater

Sam Houston State University has applied for six federal patents, three of which have already been awarded, to protect the technology and engineering associated with a "revolutionary" packaged wastewater treatment system invented by its scientists, and it has formed a company to further develop, market and sell the systems.

28 Oct 2009

Biomerica moves to new Corporate, R&D and manufacturing facility in Irvine, California

Biomerica, Inc., a global provider of advanced diagnostic products for the early detection of medical conditions, today announced their move to a new Corporate, R&D and Manufacturing facility in Irvine, California.

28 Oct 2009

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.

28 Oct 2009

PureWellness announces enhancements to the PureWellness platform

PureWellness, Inc., a leading provider of online wellness solutions, announced the release of fourteen product additions and enhancements to the PureWellness platform.

28 Oct 2009

Third-quarter fiscal 2009 results announced by POZEN

POZEN Inc., today announced results for the third quarter ended September 30, 2009.

28 Oct 2009

Third quarter 2009 financial results announced by DJO

DJO Incorporated (“DJO” or the “Company”), a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC (“DJOFL”), for the third quarter of 2009, ended September 26, 2009.

28 Oct 2009

Third-quarter fiscal 2009 results announced by Neovasc

Neovasc Inc., today announced financial results for the three and nine months ended September 30, 2009.

28 Oct 2009

Design of a consultation room can improve the quality of a visit to the physician's office

The design of a consultation room can improve the quality of a visit to the physician's office. A collaborative research study developed by Nurture by Steelcase and Mayo Clinic, was conducted to understand the extent to which a consultation room designed to support present-day clinical encounters could affect the consultation between patients and clinicians.

28 Oct 2009

Dyax reports financial results for third quarter 2009; attracts a net loss of $0.17 per share

Dyax Corp. today announced financial results for the third quarter ended September 30, 2009. Dyax will host a webcast and conference call at 10 a.m. (ET) this morning to review the financial results and corporate progress for the quarter.

28 Oct 2009

Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule

Nektar Therapeutics today announced that it has completed enrollment ahead of schedule in its Phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is Nektar's investigational proprietary compound currently being evaluated in Phase 2 clinical development in ovarian, breast and colorectal cancers.

28 Oct 2009

73% increase in antiviral prescriptions in the past two weeks: SDI

According to SDI’s Vector One®: National, antiviral prescriptions rose dramatically last week to over 648,000, an increase of more than 73% in the past two weeks. Antiviral prescriptions have climbed each week since the week ending Aug. 21, but the increases in the past two weeks have been significant.

28 Oct 2009

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Results from the largest prospective controlled ulcerative colitis (UC) trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.

28 Oct 2009

First spinal surgery in the U.S. using Osteotech's MagniFuse PC bone graft technology performed

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that MagniFuse PC (Posterior Cervical) Bone Graft, a new tissue-based product built upon the Company's proprietary MagniFuse bone graft technology platform, has been used for the first time in a spinal surgery in the United States.

28 Oct 2009

SciClone Pharmaceuticals reduces its U.S.-based workforce by 17% in research and development

SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.

28 Oct 2009

MEDNAX acquires neonatal group practice in Covington, Louisiana

MEDNAX, Inc., today announced the acquisition of a neonatal group based in Covington, Louisiana, consisting of two physicians who provide neonatal intensive care and well-baby care at St. Tammany Parish Hospital. The hospital’s Level III neonatal intensive care unit (NICU) has annual patient volume in excess of 2,500 patient days.

28 Oct 2009

MolecularMD moves core operations to expanded facility

MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.

28 Oct 2009

Vitamin Shoppe announces pricing of initial public offering; offers additional shares from stockholders

Vitamin Shoppe, Inc. today announced that the public offering of 9,096,077 shares of its common stock has priced at $17.00 per share. The shares will begin trading on the New York Stock Exchange today, October 28, 2009, under the ticker symbol “VSI.”

28 Oct 2009

Global sales volumes of Levulan Kerastick exceed one million units

DUSA Pharmaceuticals, Inc.®, a specialty pharmaceutical company focused on dermatology, announced today that global sales volumes of the Levulan® Kerastick®, an integral part of the Levulan® Photodynamic Therapy (PDT) technology platform, surpassed one million units.

28 Oct 2009

VitaSound Audio's Neuro-Compensator technology inbuilt into Sonomax Hearing Healthcare's Sono3 hearing aid

Sono3(TM), the innovative hearing aid based on patented instant custom fit technology from Sonomax Hearing Healthcare Inc. appears to have found the perfect partner in the revolutionary Neuro-Compensator(R) software technology that has been developed by Vitasound Audio Inc.

28 Oct 2009

SIDS America launches informative website about SIDS

Less than two years ago, the world came crashing in on Bill and Cheryl Darnell, SIDS America founders, when they went to wake their infant son, Billy, for his morning feeding and found him dead. Billy, who had seemed perfectly healthy just a few hours earlier, had fallen victim to Sudden Infant Death Syndrome, the leading cause of death among infants between 1 and 12 months of age in America.

28 Oct 2009

Medical News

Scientists discover that bacteria have the capability to clean wastewater

Biomerica moves to new Corporate, R&D and manufacturing facility in Irvine, California

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

PureWellness announces enhancements to the PureWellness platform

Third-quarter fiscal 2009 results announced by POZEN

Third quarter 2009 financial results announced by DJO

Third-quarter fiscal 2009 results announced by Neovasc

Design of a consultation room can improve the quality of a visit to the physician's office

Dyax reports financial results for third quarter 2009; attracts a net loss of $0.17 per share

Enrollment for Phase 2 clinical study of NKTR-102 completed ahead of schedule

73% increase in antiviral prescriptions in the past two weeks: SDI

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

First spinal surgery in the U.S. using Osteotech's MagniFuse PC bone graft technology performed

SciClone Pharmaceuticals reduces its U.S.-based workforce by 17% in research and development

MEDNAX acquires neonatal group practice in Covington, Louisiana

MolecularMD moves core operations to expanded facility

Vitamin Shoppe announces pricing of initial public offering; offers additional shares from stockholders

Global sales volumes of Levulan Kerastick exceed one million units

VitaSound Audio's Neuro-Compensator technology inbuilt into Sonomax Hearing Healthcare's Sono3 hearing aid

SIDS America launches informative website about SIDS

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News